Insulet (PODD) Divestments (2016)
Insulet's (PODD) quarterly Divestments came in at $1.1 million in Q2 2016, down 76.16% quarter-over-quarter from $4.6 million in Q1 2016.
Analysis
Insulet (PODD) Divestments (2016) Analysis & Trends
Insulet (PODD) has reported Divestments for 1 consecutive years, with $1.1 million the latest figure, recorded in Q2 2016.
- For the quarter ending Q2 2016, Divestments changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2017 stood at $1.1 million (down 76.16% YoY), and the FY2016 full-year result was $5.7 million, changed N/A from the prior year.
- Divestments fell to $1.1 million in Q2 2016 per PODD's latest filing, from $4.6 million in the prior quarter.
- Across five years, Divestments topped out at $4.6 million in Q1 2016 and bottomed at $1.1 million in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | - |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | - |